Omega Diagnostics Group PLC Posting of Annual Report and confirmation of AGM
September 27 2022 - 02:00AM
UK Regulatory (RNS & others)
TIDMODX
RNS Number : 6996A
Omega Diagnostics Group PLC
27 September 2022
OMEGA DIAGNOSTICS GROUP PLC
("Omega" or the "Company" or the "Group")
Posting of Annual Report and confirmation of AGM
Omega (AIM: ODX), the specialist medical diagnostics company
focused on industry-leading Health & Nutrition and Global
Health products, confirms that the Notice of Annual General Meeting
('AGM') along with the Annual Report and Accounts for the year
ended 31 March 2022 has been posted to shareholders yesterday
afternoon and will shortly be made available on the Company's
website at:
https://www.omegadiagnostics.com/Investor-Relations/Corporate-Information/Annual-Report-and-Interim-Results
As previously announced, the AGM of the Company will be held on
Wednesday 26 October 2022 at 11.00am at Poets House, St Mary's
Street, Ely, CB7 4EY.
Contacts:
Omega Diagnostics Group PLC www.omegadx.com
Jag Grewal, Chief Executive Officer via Walbrook PR
Chris Lea, Chief Financial Officer
finnCap Ltd Tel: 020 7220 0500
Geoff Nash/Edward Whiley/George Dollemore (Corporate
Finance)
Alice Lane/Charlotte Sutcliffe
(ECM)
Walbrook PR Limited Tel: 020 7933 8780 or omega@walbrookpr.com
Paul McManus / Sam Allen / Lianne Mob: 07980 541 893 / 07502 558 258 /
Applegarth 07584 391 303
About Omega Diagnostics Group PLC
Omega manufactures and distributes high quality in-vitro
diagnostic products for use in hospitals, clinics, laboratories and
healthcare practitioners in over 70 countries and specialise in the
areas of health and nutrition and global health.
www.omegadx.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
ACSPPUQPBUPPGQQ
(END) Dow Jones Newswires
September 27, 2022 02:00 ET (06:00 GMT)
Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From Feb 2023 to Mar 2023
Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From Mar 2022 to Mar 2023